Fresh Capital

Oct 02, 2009 (LBO) - Sri Lanka's Seylan Bank said its public share issue of 54.
online pharmacy buy spiriva inhaler with best prices today in the USA

29 million shares at 35 rupees a share to raise 1.


buy zydena online buy zydena online no prescription
9 billion rupees has been oversubscribed. "The total capital expected to be generated from both the private placement and public offering will be 3.
online pharmacy buy cymbalta with best prices today in the USA


online pharmacy buy diflucan with best prices today in the USA


buy elavil online https://qpharmacorp.com/wp-content/uploads/2023/08/png/elavil.html no prescription pharmacy



025 billion rupees," the bank said in a statement.

"This issue is primarily aimed at facilitating the future expansion of the bank.

online pharmacy buy ciprodex with best prices today in the USA


buy antabuse online https://qpharmacorp.com/wp-content/uploads/2023/08/png/antabuse.html no prescription pharmacy

"

Under a separate private placement, two state-owned entities, the Bank of Ceylon and Sri Lanka Insurance Corporation, were allocated 13 million and 19.15 million shares of Seylan Bank, formerly part of the troubled Ceylinco group.

online pharmacy buy strattera with best prices today in the USA


online pharmacy buy abilify with best prices today in the USA


buy vibramycin online https://qpharmacorp.com/wp-content/uploads/2023/08/png/vibramycin.html no prescription pharmacy



The public issue would be closed Friday afternoon and the basis of allotment will be notified to the Colombo Stock Exchange in due course, the bank said

The share issues were part of an effort by Seylan Bank to raise fresh capital to recapitalize the bank and meet statutory capital adequacy and liquidity requirements.

Seylan Bank was brought under the supervision of the banking regulator after it faced a run following the collapse of an unlisted Ceylinco group firm last year.

The central bank appointed a new boa

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
Top
0
Would love your thoughts, please comment.x
()
x